UP!

INVN $12.99

INVN target price
12.99
0
0
InvenSense
Type
Public
Traded as NYSE: INVN
Industry Consumer Electronics
Founded 2003
Headquarters San Jose, California, US
Key people
Behrooz Abdi, CEO
Products MotionTracking Sensors
Parent TDK
Website invensense.com

InvenSense Inc. (NYSE: INVN) is the provider of the MotionTracking sensor system on chip (SoC) which functions as a gyroscope for consumer electronic devices such as smartphones, tablets, wearables, gaming devices, optical image stabilization, and remote controls for Smart TVs. InvenSense provides the motion controller in the Nintendo Wii game controller and the Oculus Rift DK1. Its motion controllers are found in the Samsung Galaxy smartphones and most recently in the Apple iPhone 6. Founded in 2003, InvenSense is headquartered in San Jose, California with offices in Wilmington, Massachusetts, China, Taiwan, Korea, Japan, France, Canada, Slovakia and Italy.

In December 2016, the company was acquired by semiconductor company TDK for USD$1.3 billion.

InvenSense MotionTracking tracks complex user motions with the use of motion sensors such as microelectromechanical gyroscopes, (including 3-axis gyroscopes), accelerometers, compasses, and pressure sensors. the system then calibrates data, and creates a single data stream. With complex movement tracking comes a drain on battery life. In June, 2014, the company announced a low power gyroscope chip that used just under six milliwatts of power in a chip and was just 0.75 millimeters thick.

InvenSense also provides Optical Image Stabilisation for Smartphone cameras, which are important to detect hand movements and reduce shake in photographs. InvenSense's compact gyroscope was designed to provide antishake features on the smallest camera phones.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-07-06 Reiterated Rating KeyCorp Hold
2016-05-25 Reiterated Rating Roth Capital Buy $10.00
2016-05-11 Downgrade Canaccord Genuity Buy to Hold $10.00 to $6.22
2016-05-10 Lower Price Target Topeka Capital Markets Buy $9.00 to $8.00
2016-05-10 Reiterated Rating Roth Capital Buy
2016-05-10 Reiterated Rating Drexel Hamilton Hold
2016-05-10 Reiterated Rating Oppenheimer Hold
2016-05-10 Reiterated Rating Morgan Stanley Hold
2016-05-10 Reiterated Rating Oppenheimer Holdings Inc. Hold
2016-04-14 Reiterated Rating Pacific Crest Hold $7.00
2016-04-12 Reiterated Rating Rosenblatt Securities Neutral $10.00 to $7.20
2016-03-01 Initiated Coverage Drexel Hamilton Hold
2016-01-28 Reiterated Rating Canaccord Genuity Buy $14.00 to $10.00
2016-01-28 Lower Price Target Topeka Capital Markets Buy $14.00 to $9.00
2016-01-28 Downgrade Barrington Research Outperform to Market Perform
2016-01-13 Initiated Coverage Benchmark Co. Hold $9.00
2016-01-12 Reiterated Rating Roth Capital Buy
2016-01-08 Downgrade Rosenblatt Securities Buy to Neutral $10.00
2015-12-11 Reiterated Rating Roth Capital Buy $19.00
2015-10-29 Lower Price Target Craig Hallum Hold $13.00
2015-10-29 Upgrade Barrington Research Market Perform to Outperform
2015-10-29 Reiterated Rating Canaccord Genuity Buy $15.00 to $14.00
2015-10-29 Lower Price Target Northland Securities Market Perform $15.00 to $12.50
2015-10-29 Lower Price Target Topeka Capital Markets Buy $18.00 to $14.00
2015-10-23 Reiterated Rating Roth Capital Buy $19.00
2015-10-13 Reiterated Rating Rosenblatt Securities Buy $15.00
2015-08-13 Reiterated Rating Canaccord Genuity Buy
2015-08-05 Downgrade Barrington Research Outperform to Market Perform
2015-08-05 Lower Price Target Canaccord Genuity Buy $19.00 to $15.00
2015-08-05 Lower Price Target Ascendiant Capital Markets Buy $20.00 to $17.00
2015-08-05 Downgrade Northland Securities Outperform to Market Perform $18.00 to $15.00
2015-08-04 Reiterated Rating Roth Capital Buy $20.00
2015-06-09 Reiterated Rating Oppenheimer Hold
2015-06-08 Upgrade Northland Securities Market Perform to Outperform $17.50 to $18.00
2015-05-11 Reiterated Rating Pacific Crest Equal Weight
2015-05-11 Reiterated Rating Roth Capital Buy $22.00 to $20.00
2015-05-05 Set Price Target Ascendiant Capital Markets Buy $20.00
2015-05-05 Downgrade Craig Hallum Buy to Hold $15.00
2015-05-05 Boost Price Target Canaccord Genuity Buy $18.00 to $19.00
2015-04-14 Upgrade Rosenblatt Securities Neutral to Buy
2015-03-19 Initiated Coverage Rosenblatt Securities Neutral $15.00
2015-02-23 Initiated Coverage Barrington Research Outperform $20.00
2015-01-30 Lower Price Target Imperial Capital Outperform $23.00 to $20.00
2015-01-27 Set Price Target Roth Capital Buy $25.00 to $22.00
2014-11-13 Initiated Coverage JMP Securities Outperform $18.00
2014-10-29 Lower Price Target Imperial Capital Outperform $28.00 to $23.00
2014-10-29 Downgrade Northland Capital Outperform to Market Perform $30 to $17.50
2014-10-29 Reiterated Rating Canaccord Genuity Buy $29.00 to $21.00
2014-10-29 Reiterated Rating Goldman Sachs Neutral
2014-10-29 Downgrade Northland Securities Outperform to Market Perform $30.00 to $17.50
2014-10-29 Downgrade Piper Jaffray Overweight to Neutral $29.00 to $17.00
2014-10-29 Downgrade Pacific Crest Outperform to Sector Perform $28.00
2014-10-29 Reiterated Rating Goldman Sachs Group Inc. Neutral
2014-10-29 Downgrade Piper Jaffray Cos. Overweight to Neutral $29.00 to $17.00
2014-10-01 Upgrade Needham Buy to Strong Buy
2014-10-01 Upgrade Needham & Company LLC Buy to Strong-Buy $28.00
2014-09-22 Downgrade Robert W. Baird Outperform to Neutral $30.00 to $23.00
2014-08-18 Downgrade Goldman Sachs Buy to Neutral $25.00
2014-08-08 Initiated Coverage Canaccord Genuity Buy $29.00
2014-07-31 Boost Price Target Needham & Company LLC $22.00 to $28.00
2014-07-31 Boost Price Target Evercore ISI $25.00 to $32.00
2014-07-31 Boost Price Target Robert W. Baird $28.00 to $30.00
2014-07-30 Upgrade Ascendiant Capital Markets Neutral to Buy $29.00
2014-07-30 Boost Price Target Imperial Capital Outperform $24.00 to $28.00
2014-07-30 Reiterated Rating Topeka Capital Markets Buy $22.00 to $27.00
2014-07-30 Upgrade Morgan Stanley Buy $29.00
2014-07-30 Boost Price Target Northland Securities Outperform $24.00 to $30.00
2014-07-30 Boost Price Target Pacific Crest Outperform $26.00 to $28.00
2014-07-28 Boost Price Target Roth Capital Buy $26.00 to $28.00
2014-07-14 Boost Price Target Robert W. Baird $22.00 to $28.00
2014-06-27 Set Price Target Piper Jaffray $22.00 to $25.00
2014-06-23 Boost Price Target Pacific Crest Outperform $22.00 to $26.00
2014-05-14 Initiated Imperial Capital Outperform $21
2014-05-13 Initiated Coverage Imperial Capital Outperform $21.00
2014-05-02 Lower Price Target Topeka Capital Markets $25.00 to $22.00
2014-05-02 Lower Price Target Pacific Crest $27.00 to $22.00
2014-05-02 Upgrade Needham & Company LLC Hold to Buy $22.00
2014-05-02 Lower Price Target Evercore ISI $28.00 to $25.00
2014-04-07 Boost Price Target Pacific Crest Outperform $20.00 to $27.00
2014-04-01 Downgrade Oppenheimer Outperform to Market Perform $20.00
2014-03-28 Upgrade Roth Capital Neutral to Buy $18.00 to $26.00
2014-03-21 Boost Price Target Evercore ISI $24.00 to $28.00
2014-03-17 Boost Price Target Robert W. Baird $23.00 to $28.00
2014-03-12 Initiated Coverage Piper Jaffray Overweight
2014-03-11 Initiated Coverage Ascendiant Capital Markets Hold
2014-03-04 Boost Price Target Topeka Capital Markets $21.00 to $25.00
2014-02-26 Boost Price Target Evercore ISI $22.00 to $24.00
2014-02-11 Boost Price Target Robert W. Baird $20.00 to $23.00
2014-01-30 Reiterated Rating Goldman Sachs Buy
2014-01-30 Boost Price Target Oppenheimer $1.00 to $20.00
2014-01-30 Boost Price Target Pacific Crest $19.00 to $20.00
2014-01-02 Boost Price Target Maxim Group Buy $20.00 to $24.00
2013-11-11 Reiterated Rating Piper Jaffray Overweight $25.00
2013-10-30 Boost Price Target Topeka Capital Markets Buy $20.00 to $22.00
2013-10-30 Lower Price Target Oppenheimer Outperform $24.00 to $21.00
2013-10-30 Lower Price Target Evercore ISI Overweight $21.00 to $20.00
2013-10-30 Downgrade Roth Capital Buy to Neutral
2013-10-28 Reiterated Rating Maxim Group Buy $23.00
2013-10-15 Reiterated Rating Needham & Company LLC Buy $20.00
2013-10-15 Boost Price Target Oppenheimer Outperform $19.00 to $24.00
2013-10-15 Boost Price Target Maxim Group Buy $18.00 to $23.00
2013-09-23 Reiterated Rating Needham & Company LLC Buy $20.00
2013-09-12 Reiterated Maxim Group Buy $20 to $21
2013-09-04 Upgrade Robert W. Baird Neutral to Outperform $16 to $23
2013-08-27 Reiterated Maxim Group Buy $18 to $20
2013-08-22 Initiated Needham Buy $20
2013-06-04 Reiterated Maxim Group Buy $12 to $15
2013-05-29 Initiated Northland Capital Outperform $17.50
2013-02-27 Downgrade Robert W. Baird Outperform to Neutral $16 to $13
2013-01-10 Reiterated Maxim Group Buy $14 to $15
2012-11-13 Initiated Maxim Group Buy $14
2016-07-06 Reiterated Rating KeyCorp Hold
2016-05-25 Reiterated Rating Roth Capital Buy $10.00
2016-05-11 Downgrade Canaccord Genuity Buy to Hold $10.00 to $6.22
2016-05-10 Lower Price Target Topeka Capital Markets Buy $9.00 to $8.00
2016-05-10 Reiterated Rating Roth Capital Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Nasiri Steven Saeed 5.69%  (5060790) INVN /
Artiman, L.L.C. 0.16%  (140528) INVN /
ARTIMAN VENTURES L P 0.14%  (120429) INVN /
TACHNER ADAM H VP & General Counsel 0.08%  (72221) INVN /
Lloyd Stephen Vice President 0.05%  (46904) INVN /
KROCK ALAN Chief Financial Officer 0.01%  (5424) INVN /